EPISODE · Jun 2, 2014 · 8 MIN
Identifying High-Risk Myeloma
from Journal of Clinical Oncology (JCO) Podcast
FISH genetics, LDH and beta 2-microglobulin can identify a group of newly diagnosed myeloma patients with a two-year survival of only 52% in spite of bortezomib-based therapy.
NOW PLAYING
Identifying High-Risk Myeloma
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m